FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
| Oracin, 148296-83-7 ;148317-76-4 (free), Oracin Intermediate 5651-60-5, stock 385.8g, white powder, assay by HPLC 99.6%, HNMR, LCMS we supply. |
| Oracin, 148296-83-7 ;148317-76-4 (free), Oracin Intermediate 111-41-1, stock 488.6g, white powder, assay by HPLC 98.7%, HNMR, LCMS we supply. |
| Oracin, 148296-83-7 ;148317-76-4 (free), Oracin Intermediate 148317-76-4, stock 127.5g, white powder, assay by HPLC 98.9%, HNMR, LCMS we supply. |
| Oracin, 148296-83-7 ;148317-76-4 (free), Oracin Intermediate 148296-83-7, stock 921.2g, white powder, assay by HPLC 99.3%, HNMR, LCMS we supply. |
